Compare Exelixis Inc. Common Stock (EXEL) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Taskus Inc — how do they compare? Exelixis Inc. Common Stock trades at $59.86 (market cap $14.62B), while Taskus Inc trades at $8.14 (market cap $723.41M). The key difference: Exelixis Inc. Common Stock is far larger — about 20.2× Taskus Inc's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Taskus Inc for 34 Days on average.
| EXEL | TASK | |
|---|---|---|
Market Cap | $14.62B | $723.41M |
Volume | 2,684,957 | 201,303 |
Sector | Health | Technology |
52-Week High | $59.13 | $14.69 |
52-Week Low | $34.54 | $4.57 |
Typical Hold Time | 1 Days | 34 Days |
Enterprise Value | $13.95B | $1.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TaskUs trades at $8.14, up 3.17% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates strong fundamentals with revenue growth to $1.18B in 2025 and net income margin expanding to 8.75%. Recent Q2 2026 earnings beat expectations with $0.33 EPS versus $0.29 expected, though Q1 2026 missed estimates. Valuation metrics appear attractive with P/E of 6.8 and P/S of 0.6, suggesting potential undervaluation.
The stock presents a compelling value opportunity given its low valuation multiples and strong profitability metrics, though technical weakness and competitive pressures in AI services create near-term headwinds. Analyst consensus remains positive with a $9.33 price target representing 15% upside potential from current levels, supported by institutional accumulation including Dimensional Fund Advisors' 12.8% position increase in Q1 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
